Risks of basal cell and squamous cell carcinoma in psoriasis patients after treatment with biologic vs nonâ€biologic systemic therapies
JEADV, 2021.
Mason KJ, Burden AD, Barker J, Lunt M, Ali H, Kleyn CE, McElhone K, Soliman MM, Green AC, Griffiths CEM, Reynolds NJ, Ormerod AD
Read publication: JEADV 2021
Related
Psoriasis treat to target: defining outcomes in psoriasis using data from a real-world, population-b...
The British Association of Dermatologists Biologics and Immunomodulators Register: a centenary celeb...
Randomized Trial Replication Using Observational Data for Comparative Effectiveness of Secukinumab a...
0 Comments